等待开盘 08-28 09:30:00 美东时间
+0.170
+2.31%
Arq (NASDAQ:ARQ) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $(0.02) by 194.12 percent. This is a 16.67 percent increase over losses of $(0.06) per share from the same
08-12 04:34
Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to rep...
08-11 16:32
Arq (NASDAQ:ARQ) is gearing up to announce its quarterly earnings on Monday, 20...
08-09 03:04
今日重点评级关注:HC Wainwright & Co.:维持FibroGen"买入"评级,目标价从10美元升至43美元;摩根大通:维持Cogent Biosciences"超配"评级,目标价从29美元升至30美元
08-08 09:34
Key achievement in ongoing corporate transformationFirst GAC sales have been completedArq well positioned to meet strong GAC market demandGAC operations now shift to production scale-up, targeting 25 million pounds
08-06 20:22
Key achievement in ongoing corporate transformationFirst GAC sales have been completedArq well positioned to meet strong GAC market demandGAC operations now shift to production scale-up, targeting 25 million pounds
08-06 20:08
Arq, Inc. has achieved a key milestone in its corporate transformation by successfully commissioning its first Granular Activated Carbon (GAC) production line at its Red River Plant. The facility has entered its ramp-up phase, targeting an annualized production capacity of 25 million pounds within six months. The company has already achieved initial commercial GAC production and recorded its first sales. Arq is well-positioned to capitalize on st...
08-06 12:00
Arq, Inc. (NASDAQ: ARQ) announced it will release its second-quarter 2025 financial results and file its Quarterly Report on Form 10-Q on August 11, 2025. A conference call to discuss the results is scheduled for August 12 at 8:30 a.m. ET. The call will be webcast on Arq's website and accessible via registered links or dial-in numbers. A replay will be available post-event. Arq is a North American producer of activated carbon, focusing on environ...
07-17 11:30
Canaccord Genuity analyst George Gianarikas maintains Arq (NASDAQ:ARQ) with a Buy and lowers the price target from $9 to $8.
05-08 23:11
Arq (NASDAQ:ARQ) reported quarterly sales of $27.25 million which beat the analyst consensus estimate of $26.27 million by 3.73 percent. This is a 25.33 percent increase over sales of $21.74 million the same period last
05-07 18:32